The Effect of VSL-3 Probiotic Preparation on the Bile Acid Metabolism in Patients With Inflammatory Bowel Disease
Latest Information Update: 18 Sep 2021
At a glance
- Drugs VSL 3 (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Biomarker; Pharmacodynamics
- 28 Jul 2021 Biomarkers information updated
- 04 Mar 2013 Planned initiation date changed from 1 Mar 2013 to 1 Apr 2013 as reported by ClinicalTrials.gov.
- 24 Jan 2013 New trial record